Miriam E. Tucker
Age, C-reactive protein predict COVID-19 death in diabetes
September 29, 2021
“This means we can easily identify patients early on in their hospital stay who will likely require more aggressive interventions to try and improve survival.”
At 18 months, much still unknown about diabetes and COVID-19
September 13, 2021
“COVID-19 has had a devastating effect on the population with diabetes.”
In-hospital glucose management program gives dramatic savings
May 10, 2021
“I’ve been advocating for endocrine hospitalists to be deployed nationally,” said Dr. Misha Zilbermint.
Dr. Topol talks: COVID-19 variants are innocent until proven guilty
May 7, 2021
“The B.1.1.7 is going to be the dominant strain worldwide. It could develop new mutations within it that could come back to haunt us. We must keep watch.”
Most kids with type 1 diabetes and COVID-19 in U.S. fared well
May 3, 2021
Most children who were hospitalized had diabetic ketoacidosis (DKA) and high A1c levels.
CDC adds new medical conditions to COVID-19 high-risk list
March 31, 2021
The CDC refers to the medical conditions list as phase 1c in regard to COVID-19 vaccine prioritization.
COVID-19 can cause atypical thyroid inflammation
March 24, 2021
Patients with thyroid abnormalities during acute COVID-19, or who develop such symptoms, should have thyroid function checked every 6 months for a year.
Inpatient sodium imbalances linked to adverse COVID-19 outcomes
March 11, 2021
Hypernatremia during hospitalization was associated with increased COVID-19 mortality and to a greater need for ventilatory support.
BMI, age, and sex affect COVID-19 vaccine antibody response
March 5, 2021
Study finds that older and heavier men have lower antibody responses to the Pfizer mRNA vaccine than do younger, leaner, and female recipients.
Protecting patients with diabetes from impact of COVID-19
January 28, 2021
Comprehensive report summarizes best practices to protect those with diabetes from impact of pandemic, from prior 2-day Diabetes Technology Society meeting.